Antiretroviral treatment outcomes from a nurse‐driven, community‐supported HIV/AIDS treatment programme in rural Lesotho: observational cohort assessment at two years
Open Access
- 1 February 2009
- journal article
- Published by Wiley in Journal of the International AIDS Society
- Vol. 12 (1) , 23
- https://doi.org/10.1186/1758-2652-12-23
Abstract
Lesotho has the third highest HIV prevalence in the world (an adult prevalence of 23.2%). Despite a lack of resources for health, the country has implemented state-of-the-art antiretroviral treatment guidelines, including early initiation of treatment (<350 cells/mm3), tenofovir in first line, and nurse-initiated and managed HIV care, including antiretroviral therapy (ART), at primary health care level.Keywords
This publication has 13 references indexed in Scilit:
- Success with antiretroviral treatment for children in Kigali, Rwanda: Experience with health center/nurse-based careBMC Pediatrics, 2008
- Antiretroviral therapy and early mortality in South AfricaBulletin of the World Health Organization, 2008
- Extensively Drug-Resistant Tuberculosis, LesothoEmerging Infectious Diseases, 2008
- Expanding Global HIV TreatmentAnnals of the New York Academy of Sciences, 2008
- Payment for antiretroviral drugs is associated with a higher rate of patients lost to follow-up than those offered free-of-charge therapy in Nairobi, KenyaTransactions of the Royal Society of Tropical Medicine and Hygiene, 2008
- Implementing Antiretroviral Therapy in Rural Communities: The Lusikisiki Model of Decentralized HIV/AIDS CareThe Journal of Infectious Diseases, 2007
- Patient Retention in Antiretroviral Therapy Programs in Sub-Saharan Africa: A Systematic ReviewPLoS Medicine, 2007
- Lost to follow up: contributing factors and challenges in South African patients on antiretroviral therapy.2007
- Antiretroviral therapy for children in the routine setting in MalawiTransactions of the Royal Society of Tropical Medicine and Hygiene, 2007
- Treatment Outcomes Stratified by Baseline Immunological Status among Young Children Receiving Nonnucleoside Reverse-Transcriptase Inhibitor-Based Antiretroviral Therapy in Resource-Limited SettingsClinical Infectious Diseases, 2007